ENTITY
Amgen Inc

Amgen Inc (AMGN US)

172
Analysis
Health CareUnited States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
bearishCelltrion Inc
29 Sep 2022 16:45

Celltrion (068270 KS): Competition Makes US Approval of New Oncology Biosimilar Unappealing

Celltrion got FDA approval for its oncology biosimilar Vegzelma. However, increasing competition and price erosion in the US market, lessen...

Logo
193 Views
Share
bearishSillaJen Inc
23 Sep 2022 11:16

SillaJen Inc (215600 KS): Baselia Deal Enriches Pipeline; Stock Trading Resumption Decision Soon

Despite recent acquisition of a first-in-class oncology drug candidate, SillaJen is a risky bet amid regulatory crackdown and past clinical trial...

Logo
430 Views
Share
bullishAmgen Inc
29 Aug 2022 14:24

Amgen Inc: The ChemoCentryx Acquisition & Other Drivers

Amgen delivered strong volume-driven growth in the last quarter which resulted in the company managing an all-around beat. Many of the innovative...

Logo
235 Views
Share
07 Aug 2022 01:22

China Healthcare Weekly (Aug.5) - HK IPO, Innovent, BeiGene, the Largest IVD Centralized Procurement

IVD field ushered in the largest VBP in history. Innovent/Sanofi reached major cooperation, and Innovent’s CCO resigned. We deep dived the logic...

Logo
377 Views
Share
bearishS&P 500 INDEX
12 Jul 2022 22:33

U.S. Indexes Form Bear Flag Patterns Within Downtrends; Opportunities Within Health Care

We continue to view the price action over the past month as a bear market bounce in the S&P 500, Nasdaq 100 (QQQ), and Russell 2000 (IWM), as each...

Logo
444 Views
Share
x